Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Yoshihara

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Transplantation and Cellular Therapy|July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program RegistryJunya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Bone Marrow Transplantation|April 16, 2025
The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysisNobuhiko Nakamura, Tetsuji Morishita, Hiromi Hayashi, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
British Journal of Haematology|June 16, 2025
Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular TherapyTakaaki Konuma, Yoshimitsu Shimomura, Shohei Mizuno, et al.
Cytotherapy|January 16, 2026
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registryMasatoshi Sakurai, Yasuyuki Arai, Hideki Goto, et al.
Cytotherapy|December 3, 2024
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remissionYoshimitsu Shimomura, Tetsuhisa Kitamura, Masamitsu Yanada, et al.
American Journal of Hematology|March 2, 2026
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid LeukemiaShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Leukemia|December 10, 2024
Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERGSatoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Ejhaem|August 11, 2025
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCTTakashi Toya, Yujiro Nakajima, Konan Hara, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Transplantation and Cellular Therapy|July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program RegistryJunya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Bone Marrow Transplantation|April 16, 2025
The impact of the SARS-CoV-2 pandemic on umbilical cord blood transplantation in Japan: insights from an interrupted time series analysisNobuhiko Nakamura, Tetsuji Morishita, Hiromi Hayashi, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
British Journal of Haematology|June 16, 2025
Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular TherapyTakaaki Konuma, Yoshimitsu Shimomura, Shohei Mizuno, et al.
Cytotherapy|January 16, 2026
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: a nationwide registryMasatoshi Sakurai, Yasuyuki Arai, Hideki Goto, et al.
Cytotherapy|December 3, 2024
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remissionYoshimitsu Shimomura, Tetsuhisa Kitamura, Masamitsu Yanada, et al.
American Journal of Hematology|March 2, 2026
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid LeukemiaShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Leukemia|December 10, 2024
Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERGSatoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, et al.
Pageof 15